| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 121 | 7,451 | 2,813 | 410 |
| Restricted cash | 0 | 4,000 | NaN | NaN |
| Accounts receivable-Nonrelated Party | 596 | 623 | 892 | NaN |
| Accounts receivable | NaN | NaN | NaN | 1,300 |
| Inventory, net | 7,445 | 7,303 | 6,552 | 6,996 |
| Due from related parties | NaN | NaN | NaN | 112 |
| Accounts receivable-Related Party | 0 | 134 | 271 | NaN |
| Prepaid expenses and other current assets | 1,347 | 1,215 | 1,060 | 825 |
| Total current assets | 9,509 | 20,726 | 11,588 | 9,643 |
| Property, plant and equipment, gross | 808 | 782 | 750 | NaN |
| Less accumulated depreciation | 624 | 599 | 581 | NaN |
| Property and equipment, net | 184 | 183 | 169 | 188 |
| Finance lease right-of-use assets, net | 141 | 152 | 144 | 154 |
| Operating lease right-of-use assets, net | 284 | 363 | 474 | 550 |
| Intangible assets, net | 487 | 509 | 531 | 553 |
| Goodwill | 615 | 615 | 615 | 615 |
| Total assets | 11,220 | 22,548 | 13,521 | 11,703 |
| Accounts payable | 2,711 | 2,079 | 3,120 | 6,370 |
| Current portion of finance lease liability | 79 | 77 | 64 | NaN |
| Current portion of operating lease liability | 329 | 386 | 372 | NaN |
| Loans from related parties-Related Party | 700 | 1,000 | 0 | NaN |
| Convertible notes payable, net | NaN | 0 | 0 | NaN |
| Senior secured note | 2,157 | 5,448 | NaN | NaN |
| Derivative liability-Embedded Derivative Financial Instruments | NaN | 0 | NaN | NaN |
| Derivative liability | NaN | NaN | 0 | NaN |
| Warrant liability-Warrant Liability | 4,699 | 7,842 | NaN | NaN |
| Current portion of finance lease liability | NaN | NaN | NaN | 63 |
| Accrued interest | 4 | 6 | 0 | NaN |
| Current portion of operating lease liability | NaN | NaN | NaN | 366 |
| Loans from related parties | NaN | NaN | NaN | 6,810 |
| Convertible notes payable, net | NaN | NaN | NaN | 14,752 |
| Derivative liability | NaN | NaN | NaN | 13,711 |
| Accrued interest | NaN | NaN | NaN | 1,371 |
| Other accrued liabilities | 1,980 | 1,857 | 1,817 | 2,193 |
| Total current liabilities | 12,659 | 18,695 | 5,373 | 45,636 |
| Finance lease liability, net of current portion | 9 | 30 | 44 | 61 |
| Operating lease liability, net of current portion | 0 | 34 | 136 | 234 |
| Total liabilities | 12,668 | 18,759 | 5,553 | 45,931 |
| Preferred stock, 0.0001 par value 30,000,000 shares authorized 18,406,857 series a-1 issued and outstanding as of june30, 2025 and december31, 2024 liquidation value 26,981 and 25,405 as of june30, 2025 and december31, 2024, respectively | NaN | NaN | NaN | 20,265 |
| Common stock, 0.0001 par value 300,000,000 shares authorized 75,264,045 and 73,701,176 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 8 | 7 | 7 | 1 |
| Additional paid-in capital | 82,757 | 80,397 | 80,283 | 7,370 |
| Accumulated other comprehensive income | 246 | 228 | 230 | 262 |
| Accumulated deficit | -84,459 | -76,843 | -72,552 | -62,126 |
| Stockholders equity (deficit) | -1,448 | 3,789 | 7,968 | -54,493 |
| Total liabilities, temporary equity, and stockholders equity (deficit) | 11,220 | 22,548 | 13,521 | 11,703 |
Picard Medical, Inc. (PMI)
Picard Medical, Inc. (PMI)